We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FGBI:NASDAQFirst Guaranty Bancshares, Inc. Analysis

Data as of 2026-04-02 - not real-time

$9.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

First Guaranty Bancshares is trading at $9.20, comfortably above its 20‑day ($8.39), 50‑day ($8.69) and 200‑day ($7.70) moving averages, indicating short‑term momentum. The RSI sits at 62, suggesting continued buying pressure without being overbought, and the MACD histogram is positive with a bullish signal line crossover. Technical support sits near $7.83 while resistance is around $9.35, placing the current price just below the next upside barrier. Fundamentally, the stock appears cheap – forward P/E of 14.2 versus an industry average of 16.6 and a P/B of 0.75 – but earnings are still weak (trailing EPS –$4.17, forward EPS $0.65) and profitability metrics (ROE –23%, operating margin 14.8%) remain negative. The recent Q4 earnings surprise (+$0.28 EPS versus a consensus loss) offers a positive catalyst, yet the dividend yield of 0.45% is backed by a payout ratio of 200%, flagging sustainability concerns. Volatility is high at 44% over the past 30 days, beta is modest at 0.8, and the stock has experienced a historic max drawdown of ~57%, underscoring notable downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just below resistance at $9.35
  • Bullish MACD and RSI above 60
  • Recent earnings beat providing short‑term upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive valuation relative to peers (low P/E and P/B)
  • Weak profitability and negative ROE limiting earnings growth
  • High volatility and historic drawdown indicating potential pullbacks

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained negative earnings and margins
  • Unsustainable dividend payout ratio of 200%
  • Exposure to regional banking credit cycles and regulatory pressures

Key Metrics & Analysis

Financial Health

Revenue Growth3.40%
P/E Ratio14.2
ROE-23.28%
ROA-1.39%
P/B Ratio0.8
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI62.5
Support$7.82
Resistance$9.35
MA 20$8.39
MA 50$8.69
MA 200$7.70
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

Target Price$9.00
Upside/Downside-2.17%
GradeUndervalued
TypeValue
Dividend Yield0.45%

Risk Assessment

Beta0.80
Volatility44.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.